| ANAPTYSBIO INC. DL-,001 |
| USA |
| Gesundheit |
| US0327241065 / A2AJ8C |
| AN6 (Frankfurt) / ANAB (NASDAQ) |
| FRA:AN6, ETR:AN6, AN6:GR, NASDAQ:ANAB |
| - |
| https://www.anaptysbio.co.. |
|
AnaptysBio Inc. is a clinical-stage biotechnology ..
>Volltext.. |
| 1042.4 Mio. EUR |
| 1125.65 Mio. EUR |
| 145.66 Mio. EUR |
| -22.57 Mio. EUR |
| -72.74 Mio. EUR |
| -2.4 EUR |
| 297.78 Mio. EUR |
| 94.4 Mio. EUR |
| -124.7 Mio. EUR |
| 6.53 |
| 181.25% |
| 51.53% |
| - |
| - |
| - |
| ANAPTYSBIO |
| 10.01.26 |